Background Evidence has accumulated showing that blood pressure variability is associated with cardiovascular disease. A substantial increase in the prevalence of obesity has been documented globally. Our objective was to examine the relation of total and central obesity on visit-to-visit blood pressure variability.
Introduction
Hypertension is an important public health problem affecting 25% of the adult population in western countries and over 1 billion people worldwide. 1 It is a major risk factor for many causes of morbidity and mortality in the general population, including stroke, myocardial infarction and congestive heart failure. 2 Currently, .73 million Americans have hypertension, and the prevalence of hypertension is particularly high in African Americans. 3 Based on results of the National Health and Nutrition Examination Survey (NHANES), the age-adjusted prevalence of hypertension in the population 18 years and older is 39.1% in non-Hispanic blacks and 28.5% in non-Hispanic whites. 4 Epidemiological studies have shown that blood pressure is not a constant variable, and it undergoes profound and spontaneous oscillations over shortterm as well as long-term periods. 5 Evidence has accumulated showing that the blood pressure variability is associated with organ damage. 6 Several observational studies have documented that the harmful cardiovascular (CV) consequences of high blood pressure not only depend on absolute blood pressure values, but also on blood pressure variability. 7, 8 Hence, blood pressure fluctuations are strongly associated with CV morbidity and mortality. 7 Increased visit-to-visit blood pressure variability has been associated with an increased risk of allcause mortality among a general population (n ¼ 956) enrolled in the NHANES III study. 9 Thus, visit-to-visit variability of blood pressure has emerged as an exciting area of research. 10, 11 A substantial increase in prevalence of obesity has been documented globally. 12 In the USA, overweight and obesity are the second leading cause of preventable death in the USA, affecting 97 million adults. 13 Body mass index (BMI), an indicator for total adiposity, has long been an important measure of excess body fat, and it is a well-recognized risk factor for cardiometabolic disorders. Additionally, BMI is easily obtained and commonly assessed in clinical visits. 13 Current World Health Organization guidelines employ the following standards to define normal weight (BMI ¼ 18.5 -24.9), overweight (BMI ¼ 25 -29.9) and obese (BMI ! 30).
14 Abdominal obesity, a state of excessive accumulation of both central subcutaneous and visceral fat, is considered an important predictor for metabolic complications and adverse health effects. 15 It has been linked to type 2 diabetes, and CV disease in both adult men and women. 16 Waist circumference (WC), an indicator of visceral fat, is more sensitive to the distribution of body fat than is BMI 17 and therefore a better surrogate measure of central adiposity. Recent trends in total and abdominal obesity show that between 1999 and 2008, obesity increased in both men and women. 18 To our knowledge, no studies using population-based data have assessed the association between total or regional (central) obesity and blood pressure variability (visit-to-visit variability). Therefore, the aim of this study is to shed light on the relation between obesity (total and central) and visit-to-visit blood pressure variability.
Materials and methods
Between 1988 and 1994, the National Center for Health Statistics conducted the third National Healthy and Nutrition Examination Survey (NHANES III). This cross-sectional study consisted of a multistage, stratified, clustered probability sample of the US civilian, non-institutionalized population. Because NHANES III is based on a complex multistage probability sample design, appropriate probability sampling weights were assigned to produce unbiased population estimates. The sampling weights incorporate the differential probabilities of selection and adjust for non-coverage and non-response. The NHANES III data set was utilized to evaluate the relationship between obesity and blood pressure variability. The data set included US adults who participated in the interview conducted at home and who had data available from their physical and laboratory examinations. NHANES III consisted of a standardized questionnaire administered in the home by a trained interviewer followed by a detailed physical examination at a Mobile Examination Center (MEC). Blood pressure was measured using a mercury sphygmomanometer while the study participant was sitting all the way back in their chair so that his/her spine would be straight, according to the standardized blood pressure measurement protocols recommended by the American Heart Association. Blood pressure was measured 3 times during the in-home interview (first visit) and 3 additional times during the MEC visit (second visit). The research assistant/physician waited at least 1 min between readings. The MEC visit was scheduled within 1 month of the in-home interview. Additional details regarding blood pressure measurement and quality control procedures are provided in the NHANES III manual of operations (http://www.cdc.gov/ nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/bpqc.pdf).
The NHANES obesity measures were taken in one of the trailers of the MEC. A health technologist and recorder worked as a team to collect those data. The results were saved in the study database. The BMI was calculated as weight in kilograms divided by height in meters squared and was rounded to the nearest tenth. A measure tape was used to determine participants' WCs, and the measures were recorded in centimeters. Males who had WC .102 cm and females with WC .88 cm were classified as participants with large WC.
Self-reported data collected at the home interview relevant to the proposed analysis include demographics (age, race and gender). During the visit to the MEC, venous blood specimens were drawn from each participant according to a standardized protocol to measure blood cotinine. Cotinine concentration in the blood, a metabolite of nicotine, was used as a biomarker to classify participants into smokers and nonsmokers. A previous study utilized NHANES data set recommended considering persons with cotinine concentrations .3 ng/ml as smokers. 19 Therefore, smokers were defined as those with cotinine measurements .3 ng/ml, whereas those with blood cotinine of 3 ng/ml were considered non-smokers.
Statistical analysis
All analyses were performed by using Stata version 12, which took into account the complex sampling designs used in NHANES III. The average systolic blood pressure of each visit ðA 1 ; A 2 Þ was calculated using the following formula:
The mean systolic blood pressure of the two visits was calculated using the following formula x ¼ ðA 1 ; A 2 Þ=2. Finally, the standard deviation, a measure of systolic blood pressure variability, was calculated using the following formula:
. The previous formulas were utilized to calculate diastolic blood pressure variability.
Observations were weighted using weights calculated for that purpose by the National Center for Health Statistics to reflect the general US population. To determine the appropriate distribution that fits the study outcomes (systolic and diastolic blood pressure variability), Normal, Gamma and Lognormal distributions were fitted. Goodness-of-fit tests using gamma distribution produced the best fitting model for our data. We used a directed acyclic graph (DAG) to select a minimal sufficient set of covariates that we needed to include in a multivariable model (Fig. 1) . Our DAG indicated that adjusting for the effect of age, gender, race and smoking status could reduce confounding while we were quantifying the relationship between obesity measures and blood pressure variability. A univariate, generalized linear model (family ¼ gamma, link ¼ identity) was performed to evaluate the effect of age, gender and race on BMI and WC on systolic blood pressure variability. Epidemiologic studies have shown that age, race and smoking can confound the relationship between blood pressure variability and any potential risk factor. 20 Hence, the covariates age, race and smoking were included in a multivariable, generalized linear model (family ¼ gamma, link ¼ identity) to adjust for their effect while assessing the effect of BMI and WC on systolic blood pressure variability. In the previous analyses, WC and BMI were included separately in the regression models because of their strong relationship with each other (collinearity). Variables such as diabetes mellitus and blood cholesterol levels were not included as confounders in the multivariable model, because they can be potential intermediate factors on the pathway between obesity and blood pressure variability. 21 The previous steps were also employed to study the relationship of diastolic blood pressure variability with obesity indicators.
Results
The study included 14 988 participants. Their mean age was 43.45 years. The mean standard deviation of systolic blood pressure across study visits was 6.89 mmHg. The mean standard deviation of systolic blood pressure across visits was more likely to be higher among whites, smokers and obese individuals (Table 1) . Additionally, individuals with higher standard deviation of systolic blood pressure across study visits were more likely to have a large WC and to be hypertensive ( Table 1 ). The standard deviation of systolic blood pressure across visits was associated with race -ethnicity, smoking, hypertension, obesity, large WC and older age (Table 1) . In the multivariable model, BMI and larger WC categories were associated with higher standard deviation of systolic blood pressure across study visits (Table 2) . Neither the bivariate nor the multivariable analyses showed significant relationships between the obesity indicators, namely WC and BMI, and diastolic blood pressure variability (Supplementary data, Table S1 ).
Discussion Main findings of this study
In this cross-sectional study, total and central obesity indicators, namely BMI and WC, were associated with higher variability of systolic blood pressure across study visits. However, the same indicators did not show any significant association with visit-tovisit diastolic blood pressure variability. Several metrics have been utilized to quantify visit-to-visit blood variability in epidemiological studies. 22 We decided to utilize standard deviation as the only indicator for blood pressure variability, because a recent study has revealed that intra-individual visit-to-visit gauged by standard deviation is tightly correlated with the other measures. 22 Second, calculating several metrics that capture the same aspect of visit-to-visit blood pressure variability will not convey additional data on the relationship with outcome. 22 What is known about this topic Visit-to-visit blood pressure variability has been shown to be a reproducible and not a random phenomenon. 23 Blood pressure fluctuations are strongly associated with CV morbidity and mortality. 7 Human and animal studies have linked obesity to arterial stiffness via some metabolic changes such as insulin resistance and high free fatty acids concentration that Systolic blood pressure variability for 43.45 years old (mean age of the study population). *Significant at 5%. **Significant at 1%.
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occur with obesity. 24 -30 Arterial stiffness has been posited as an important cause for systolic arterial blood pressure variability. 31 Therefore, we postulate that the noticed significant relationship between obesity and visit-to-visit blood pressure variability in this study can be possibly attributed to arterial stiffness. The mechanical stress that is placed on the vasculature as a result of increased variability of blood flow pursuant to blood pressure variability may induce a subclinical inflammatory vascular response that leads to endothelial cell damage. 32 The consequent vascular endothelial dysfunction due to endothelial damage can impair the vasodilatory mechanisms of the arteries supplying different important organs such as the heart and brain and therefore the CV risk increases. 33 
What this study adds
This study has public health and clinical implication. Hypertension and visit-to-visit blood pressure variability are common in clinical settings. 20, 34, 35 Visit-to-visit blood pressure variability is a strong predictor of CV morbidity. 20, 34, 36, 37 The strength of the association of blood pressure variability with CV outcomes is larger than that of average blood pressure values. 8 Thus, stabilization of blood pressure fluctuation between clinic visits in obese individuals may be warranted. This could be achieved by reducing patients' body weights, regular exercise, eating healthy food, adequate dosing and titration of antihypertensive treatment and by improving patient adherence to prescribed drugs.
Limitations of this study
This study should be interpreted in the context of its limitations. The calculation of visit-to-visit blood pressure variability was based on six blood pressure measurements that were taken during two visits (three blood pressure measurements in each visit). It may be possible to derive a more reliable estimate of variability, i.e. standard deviation if more measurements were available. Second, the first set of blood pressure measurements was taken during an in-home examination by research assistants, whereas the other set of measurements were obtained and recorded in a medical evaluation conducted in a MEC by physicians. Blood pressure measurements obtained in this manner are subject to substantial error. 38 Nevertheless, a standardized study protocol and identically calibrated equipment were utilized to take all blood pressure measurements. Finally, the cross-sectional nature of these analyses did not allow for inference of causality or for establishment of the temporality between systolic blood pressure variability and obesity.
In spite of the previous limitations, this study is unique. First, the study findings can be generalized to US adults, because NHANES III is a large probability sample of the general population. Second, the large sample size of NHANES III provided sufficient power to detect a small but important association between obesity and blood pressure variability. Third, our study provided the opportunity to evaluate the association of obesity and blood pressure variability for the first time. It is noteworthy to mention that the reported study estimates have small magnitudes. However, it is important to distinguish between the implications of individual and population changes in blood pressure. At the population level, even a small upward shift in blood pressure would be expected to result in a substantial increase in CV disease and vice versa.
In summary, the findings from this study suggest that obesity is associated with visit-to-visit systolic blood pressure variability. Additional research is required to replicate the reported results in prospective studies, posit mechanisms involved in this observed association and evaluate approaches to reduce systolic blood pressure variability observed in clinical settings among obese persons to reduce its subsequent complications.
